期刊名称：DRUGS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Drugs - The definitive guide to optimizing drug therapy
For over 35 years Drugs has been the definitive journal of drugs and therapeutics, providing independent and crucial information authored by leading international clinicians and researchers.
Drugs prestigious and truly international Honorary Editorial Board ensures content of the highest quality to support clinical decision-making.
Through a rigorous and comprehensive program of peer-reviewed evaluations Drugs provides detailed and genuinely objective analysis covering the full spectrum of new and established drug therapies in all disease areas.
Opportunity to Publish
To complete its extensive coverage of drug therapy in all clinical indications, Drugs is now accepting high quality original research.
To contact the journal's editorial team please email drugs@adis.co.nz
Indexed
Indexed in MEDLINE, EMBASE/Excerpta Medica, International Pharmaceutical Abstracts (IPA), BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Current Contents/Clinical Medicine, Current Contents/Life Sciences, SciSearch, Science Citation Index, Journal Citation Reports/Science Edition, Prous Science Integrity, CINAHL, PASCAL, Chemical Abstracts Service, Sociedad Iberoamericana de Información Científica (SIIC) and Journals@OVID.
Instructions to Authors
Submission of original research to all International Review Journals with the exception of Drugs is encouraged.
Suggestions for article topics (and potential authors) for consideration by the editors and editorial boards are welcome at any time. If you are interested in preparing a review, please contact the journal with your proposed outline to confirm suitability. You should also review the policy statements for review articles and original research and Adis Drug Evaluations and Adis Drug Profiles.
The following PDF documents contain instructions and information for the preparation and layout of documents for submission.
¡¤ Original Research
All Adis International Review Journals, aside from Drugs, consider Original Research Articles for publication.
Please refer to the Instructions for Authors of the specific journal you are interested in to determine the desired article types.
¡¤ Current Opinion
A Current Opinion article should be a succinct commentary on the topic proposed, not an exhaustive review. The overall objective is to place in perspective an area of current international interest that may be controversial, and for this reason personal opinion, clearly identified as such, is welcome. The arguments presented may be controversial, but at the same time must be balanced and rational. In addition, the article should be of international scope.
Therapy in Practice
The intention of a Therapy in Practice article is to provide a succinct, clinically orientated guide to management of a particular disease or condition. The article need not be heavily referenced, although important points and definitive statements should be supported by appropriate literature citations. There is room for some personal opinion if it is clearly identified as such. However, the internationally accepted consensus on appropriate therapeutic guidelines should be the aim.
¡¤ Leading Article
A Leading Article should be a short, balanced review of a relatively small literature base, typically of a new or developing topic, that should provide an overview of the current state of development of the area being written about. The article should be fully referenced and of international scope.
¡¤ Review Article
The Review Article should be an authoritative, comprehensive and critical review of the literature, reflecting the current state of accepted international medical practice or clinical research in a particular area. The article must present a balanced, rather than personal, review of the literature, and should be fully referenced. Wherever possible, literature should be evaluated rather than simply restated. Furthermore, all therapies of relevance to the topic should be discussed in order to provide full coverage of the spectrum of agents used in the disease area or drug category under discussion.
Reference Style Guide
References are required to support all significant statements. They are also used to indicate the origin of material (quotations, tables, figures), and as a source for research and further reading. They need to be given in a form where the reader can quickly and easily identify the correct reference and locate the material in a library or on a database.
Our referencing system is based on the 'Uniform Requirements for Manuscripts Submitted to Biomedical Journals' (the 'Vancouver' style), with some minor modifications.
It is important to adhere to the style set out here (e.g. superior numbers inside square brackets in the text), which will facilitate processing.
Specific Journal Variations
Clinical Drug Investigation
All articles in Clinical Drug Investigation are submitted.
Information on the content, formatting and layout of articles for submission is available in this PDF.
Why use Pharmaceutical Reprints?
Reprints are an excellent, cost-effective tool for one-to-one marketing, conferences and seminars, sales rep support and mailing new product information to a wide audience.
You can use Pharmaceutical reprints to:
¡¤ distribute to conference delegates in packs or on your stand
¡¤ as a door-opener for sales reps
¡¤ support new product launches and product development
¡¤ update target audiences with your key messages
¡¤ disseminate information on your product to a wider audience.
Permission:
Requests for permission to photocopy, republish or mount Adis material on either an intranet or internet site should be sent via mail, fax or email to:
Permissions for UK, Europe and rest of world:
Corey Eberhart
Pharma Licensing Manager, Europe Asia-Pacific
Wolters Kluwer Health
Lippencott Williams & Wilkins
351 W Camden Street
Baltimore, MD 21201
USA
ceberhar@lww.com
Fax: +1 410 528 4331
Permissions for USA:
Kristin Mobley
Adis International
860 Town Center Drive
Langhorne
PA19047
USA
kristin.mobley@adis.com
Fax: +1 215 741 2502
Editorial Board
¡¤ R. Abernethy, Baltimore, MD, USA
¡¤ S. Bank, New York, NY, USA
¡¤ P.J. Barnes, London, England
¡¤ P.N. Bennett, Bath, England
¡¤ W.M. Bennett, Portland, OR, USA
¡¤ G. Bianchi Porro, Milan, Italy
¡¤ W.R. Bowie, Vancouver, B.C., Canada
¡¤ A.M. Breckenridge, Liverpool, England
¡¤ L. de Angelis, Trieste, Italy
¡¤ F.T. Fraunfelder, Portland, OR, USA
¡¤ E.D. Freis, Washington, DC, USA
¡¤ W.H. Frishman, Valhalla, NY, USA
¡¤
¡¤ B.G. Gazzard, London, England
¡¤ D.C. Harrison, Cincinnati, OH, USA
¡¤ F.D. Hart, London, England
¡¤ E.C. Huskisson, London, England
¡¤ G.D. Johnston, Belfast, Northern Ireland
¡¤ A.J. Krentz, Southampton, England
¡¤ M.H. Lader, London, England
¡¤ M.J.S. Langman, Birmingham, England
¡¤ H. Lode, Berlin, Germany
¡¤ H.I. Maibach, San Francisco, CA, USA
¡¤ F.H. McDowell, White Plains, NY, USA
¡¤ A.P. MacGowan, Bristol, England
¡¤ F.M. Muggia, New York, NY, USA
¡¤ K.G. Naber, Straubing, Germany
¡¤ S. Nattel, Montreal, Que., Canada
¡¤ C.E. Nord, Huddinge, Sweden
¡¤ H. Pardell, Barcelona, Spain
¡¤ P. Patsalos, London, England
¡¤ R. Pauwels, Ghent, Belgium
¡¤ B.N.C. Prichard, London, England
¡¤ S.H. Roth, Phoenix, AZ, USA
¡¤ S. Shuster, Suffolk, England
¡¤ B.N. Singh, Los Angeles, CA, USA
¡¤ T.M. Speight, Auckland, New Zealand
¡¤ J.S. Turner Jr., Gainesville, GA, USA
¡¤ J. Turnidge, Adelaide, SA, Australia
¡¤ J.A. Vale, Birmingham, England
¡¤ D.J. Zegarelli, New York, NY, USA
Editorial Staff:
Editor:Dene C. Peters
E-mail:journalDRU@adis.co.nz Publication Manager: Angela Kitt
E-mail:journalDRU@adis.co.nz
|
刊名字顺( Alphabetical List of Journals):
返回页首 